Federation of Bakers launches revised flour dust guidance

first_imgSource: Getty ImagesThe Federation of Bakers (FOB) has published revised guidance on dust control in bakeries.Called Dust Control and Health Surveillance in Bakeries, it addresses what the Federation describes as one of the most significant occupational health risks in the bakery industry – respiratory exposure to flour and other ingredient dusts.The review was carried out by the FOB Health & Safety Committee, which includes representatives from all sectors of the bakery industry including the Craft Bakers and Scottish Bakers.The ‘blue book’ first appeared in the 1980s and was last revised in 2008. It has now been updated again and reissued as a PDF download available from the Federation’s website.It provides information and advice for bakers and others working in the food manufacturing industry which, if followed, will help them reduce risk arising from employee exposure to flour and other ingredient dusts, said FOB.Following the guidance will also help employers in the industry meet their duty of care for employees and contribute to ensuring health and safety compliance, it added. In particular, the guidance provides advice on how to assess dust levels in the workplace and outlines a range of practical measures which can be taken to reduce dust exposures as low as reasonably practicable.“I am sure that as before the revised guidance will be read and used throughout the baking and wider food industry,” said FOB chief executive Gordon Polson.“I would like to thank all members of the FHSC who have given many hours of their time to the review of this essential industry guidance.”The Federation represents the UK’s largest baking companies who manufacture sliced and wrapped bread, bakery snacks and other bread products. Its members include: Fine Lady Bakeries, Jackson’s Bakery, Roberts Bakery and Warburtons.To find out more about the dangers dust can present in a bakery, read our feature: ‘Dust: a danger that can’t be ignored’.last_img read more

Exciting Special Guest Singers Announced For Tonight’s All-Star Prince Tribute

first_imgTonight at Brooklyn’s The Hall at MP, a special tribute to Prince will take place with a house band that consists of Aron Magner (The Disco Biscuits), Marcus Rezak (Stratosphere All-Stars), Mike Greenfield (Lotus), and Louis Cato (Late Show With Stephen Colbert). The show will now feature an incredible horn section, with James Casey (Trey Anastasio Band), Maurice “Mobetta” Brown (Tedeschi Trucks Band, The Roots, Wyclef Jean & more), and Ian Gray (Swift Technique) will be adding brass flare.It has just been announced that Con Brio’s Ziek McCarter, Mayteana Morales of The Pimps of Joytime, Hayley Jane of Hayley Jane and the Primates, and Nephrok of the Nephrok All-Stars will be sharing vocal duties throughout the night in this very special tribute. Ziek McCartner recently fronted Karl Denson’s Tiny Universe for a Prince tribute in New Orleans, and all four singers are eager to perform selections from the Purple One’s iconic catalog.Doors for the event open at 10pm with a set from DJ Logic, followed by the very special set of Prince songs. You can find tickets for the show by heading HERE.Karl Denson w/ Con Brio’s Ziek McCarter performing “Head” on Jam Cruise:Full Lineup:Aron Magner (The Disco Biscuits)Mike Greenfield (Lotus)Louis Cato (The Late Show with Stephen Colbert) Marcus Rezak (Stratosphere All-Stars)James Casey (Trey Anastasio Band)Maurice “Mobetta” Brown (Tedeschi Trucks Band)Ian Gray (Swift Technique)Nephrok! (The Nephrok! Allstars)Hayley Jane (Hayley Jane and the Primates)Mayteana Morales (Pimps of Joytime)Ziek McCarter (Con Brio)Opener: DJ Logiclast_img read more

New hope for treating ALS

first_imgHarvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital (MGH) to design an initial clinical trial testing the safety of the treatment in ALS patients.The investigators all caution that a great deal of work needs to be done to assure the safety and efficacy of the treatment in ALS patients before physicians should start offering it.The work, laid out in two related advance online publications in April by Cell Stem Cell and Cell Reports, is the long-term fruit of studies by Harvard Stem Cell Institute (HSCI) principal faculty member Kevin Eggan, who in a 2008 Science paper first raised the possibility of using ALS patient-derived stem cells to better understand the disease and identify therapeutic targets for new drugs.Now Eggan and HSCI colleague Clifford Woolf have found that the many independent mutations that cause ALS may be linked by their ability to trigger abnormally high activity in motor neurons. Using neurons derived from stem cells made from ALS patient skin cells, the two research teams conducted clinical trials of the anti-epilepsy medication on neurons in laboratory dishes, finding that it reduced the cells’ hyperexcitability.ALS is a devastating and currently untreatable degradation of motor neurons, the long nerve cells that connect the spinal cord to the muscles of the body. While several potential treatments have looked promising in mice, all proved disappointing in the clinic.“The big problem in ALS is that there are more than 100 mutations in dozens of genes that all cause the disease, but almost all of the therapeutics that have gone forward in the clinic have done so for just one of those mutations, SOD1, which almost everyone studies in mice,” said Eggan, a professor in Harvard’s Department of Stem Cell and Regenerative Biology.“And so,” he continued, “the key question that we really wanted to address was: Are clinical efforts failing because the mouse is taking us on a wild goose chase, or is it simply that people haven’t had the opportunity to pretest whether their ideas are true across lots of forms of ALS?”In the Cell Stem Cell study, Eggan and postdoctoral fellow Evangelos Kiskinis led an effort to make stem cell lines from two women with ALS who have SOD1 mutations in order to compare human biology and mouse biology. Using a technology called RNA sequencing to look at how the mutation changed gene expression in these lines, the researchers then traced the changes to their impact on biological pathways.“We found that the mutation makes changes in the motor neurons, which aren’t so different from the changes that you see in the mice,” Eggan said. “I think our paper says that while there are definitely some human-specific biology, the mice weren’t totally misleading.”Eggan’s lab then created more stem cell-derived motor neurons from patients with another form of ALS, as well as people without the disease, to see what changes occurred in ALS cells and if these were present across independent genetic mutations.The surprising result, described in the Cell Reports study, was that the motor neurons that possessed ALS mutations had a sporadic increase in neuron firing, while the healthy neurons were quiet unless stimulated in some way.The ALS hyperexcitability was further examined by Woolf’s team, led by Harvard Medical School neurologist Brian Wainger. Working with Eggan and Kiskinis, they found a cyclical relationship between the increased neuron activity and abnormal protein folding. In the two papers, they describe how the overexcitable ALS neurons generate more abnormally folded proteins, further increasing their excitability. The strain of this cycle seems to put the neurons in a vulnerable state, where they are more likely to die.“The convergence on a single mechanism offered a very attractive place to intervene therapeutically,” said Woolf, a Harvard Medical School professor in neurology and neurobiology and director of the neurology center at Children’s Hospital Boston, who also co-leads HSCI’s Nervous System Diseases Program.“It looked like there’s a deficit in potassium channels in the ALS motor neurons, and that led us to then test whether drugs that open the potassium channels may reduce this hyperexcitability. And indeed that’s exactly what we found,” he said. “We found that retigabine, which has recently been approved as an anticonvulsive, normalized this activity. So now we can formally go from the dish to the patient and actually explore whether the drug might have any beneficial effect.”MGH neurologist Merit Cudkowicz, with Wainger, will be running the clinical trials, which will first test for side effects in ALS patients treated with the drug. The researchers caution against calling this work a breakthrough or having doctors prescribe this drug to patients immediately. Clinical trials are necessary to determine whether there are any unusual interactions between the drug and ALS, since having a particular disease can make someone more sensitive to certain types of drugs.“The whole intact nervous system is more complicated than the cells that we have in the dish at the moment,” Eggan said. “And now the next step is to say whether or not the drug will be helpful in that context, and it’s too early to say for sure.”The scientists credit emerging technologies and the unique collaboration between a stem cell lab and a neuron physiology lab as an essential part of making this research clinically relevant for ALS patients.“I think it’s the beginning of a complete change in the way we do medicine for serious diseases like this,” Woolf said. “In a traditional clinical trial, you give the patient the placebo or an active ingredient to see the effects they have, and it’s over. Here we can take the same stem cell lines and have an infinite capacity to do clinical trials in a dish.”Funders of the research include Target ALS, Project A.L.S., P2ALS, the National Institute of Neurological Disorders and Stroke, the Howard Hughes Medical Institute, the National Institutes of Health Director’s Pioneer Award, Harvard NeuroDiscovery Center, the ALS Association, the American Brain Foundation, ALS Therapy Alliance, the Angel Fund, Pierre L. de Bourgknecht ALS Research Foundation, Al-Athel ALS Research Foundation, ALS Family Charitable Foundation, and the New York Stem Cell Foundation.last_img read more

Twelve-year FARC Hostage, Colombian Sergeant Escapes

first_img Colombian Police Sergeant Luis Alberto Erazo returned to Bogotá on November 27, after 12 years of captivity by FARC rebels, a day after managing to escape during a battle as four other hostages were executed. Erazo, 40, who had been held by the Marxist rebels since December 9, 1999, arrived in the capital by helicopter and was taken in an ambulance to a hospital for treatment, according to an AFP journalist at the scene. The sergeant, who suffered shrapnel wounds to the face as rebels in hot pursuit tossed a grenade at him, made no comment to the media. He was reunited with his girlfriend, his 16-year-old daughter and other family members. Erazo escaped from a rebel encampment in southern Colombia on November 26, where Colombian Army forces were hunting for possible hostages. During the clash, FARC rebels executed four hostages but Erazo was later found alive. President Juan Manual Santos visited Erazo on November 27, saying it was “really moving to see this national hero” but also hailing the “heroism” of the four hostages killed “in cold blood.” Santos also said he had “mixed feelings, seeing the happiness of this sergeant and his family, while at the same time understanding the pain of the other four families.” The hostages had been held at a FARC encampment in the remote Solano region of southern Colombia. Those who died were identified as Colonel Edgar Yesid Duarte, Lieutenants Elkin Hernandez and Alvaro Moreno, and Sergeant Jose Libio Martinez, the FARC’s longest-held hostage who was abducted nearly 14 years ago in a rebel ambush. After the latest executions, 14 police and soldiers remain in FARC hands. Some have spent more than a decade in captivity. By Dialogo November 29, 2011last_img read more

Alleged Female Guerrilla Member Dies in Clash with Peruvian Military

first_img The command stated that the operation was conducted after “strong intelligence operations, where information about the alleged location of camps occupied by criminals in the area of Vizcatán was obtained.” Shining Path is a Maoist guerrilla that was almost completely disrupted in the mid 1990s, the main leaders of which are serving life sentences in prison. However, it still has supporters in some areas of the Peruvian jungle. The authorities explained that the actions were carried out with full knowledge and participation of the Public Prosecutor’s Office. During the joint operation between the armed forces and the police “several camps used by terrorists were destroyed and ammunition was seized, as well as an abundance of subversive material,” announced the command. By Dialogo March 01, 2013 The operation was performed in the area of Vizcatán, Llochegua district, province of Huanta, in the Apurimac, Ene, and Mantaro River Valley (VRAEM). “During the operation that started on February 23, up to three confrontations between public forces and terrorist criminals took place in which an unidentified woman was killed,” said the statement. An alleged female guerrilla member from Shining Path was killed in a clash with military and police patrols in the area of Ayacucho, the Armed Forces Joint Command informed on February 27. Shining Path started to operate in the country in 1980, and the internal conflict killed about 70,000 people after two decades, according to the local Truth and Reconciliation Commission.last_img read more


first_img June 1, 2006 Errata Errata A story in the April 30 Bar News misspelled the name Scott Rubin, the member of the Special Committee to Study Paralegal Regulation, who presented the committee’s finding to the Bar Board of Governors. The News regrets the error. Erratalast_img

2 Killed in Brentwood Tried to Beat Train, LIRR Says

first_imgSign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York Two people were killed when their car was struck by a Long Island Rail Road train in Brentwood after the car drove around the crossing gate three miles down the track from a where similar incident occurred about two years prior.The eastbound non-passenger train was heading to the Ronkonkoma yard while traveling at the maximum allowable speed of 80 mph when it hit the 2010 Nissan at the Second Street crossing just west of the station at 10 a.m. Tuesday, officials said.“At the point of impact, apparently the car burst into flames,” said Sal Arena, an LIRR spokesman, noting that the engineer honked the horn and hit the emergency brakes but couldn’t stop in time. “When it came to a halt, the burning continued.”MTA police are waiting for Suffolk County medical examiners to complete the victims’ autopsies to confirm the identities of the victims, whose bodies were burned beyond recognition.The engineer, conductor and assistant conductor aboard the train were not injured. The front of the train was badly burned and the vehicle was partly lodged under the first car.Brentwood Fire Department firefighters extinguished the flames. MTA police then pulled the victims from the wreckage.Witnesses told MTA police that they saw the car drive around the gates, which were down with lights flashing at the time, Arena said. He added that computer data has confirmed the accounts of witnesses and LIRR workers that the gates were down at the time.Service was suspended and buses replaced trains for about five hours between Farmingdale and Ronkonkoma while crews repaired a third rail that was damaged in the crash. Service was restored in time for the evening eastbound rush hour commute.The incident is similar to a May 17, 2011 incident in which a bread delivery truck driver was killed when he tried to beat the train by going around the gate just east of the Deer Park station—the next stop west of the Brentwood station.last_img read more

Man U announce £140m debt

first_imgRelatedPosts Player prices may go down after COVID-19 pandemic — Southampton manager Angry Man U fans attack Ed Woodward’s mansion EPL: Newcastle dare Red Devils Manchester United have announced their net debt has increased by almost £140 million in their latest financial figures, even after posting another revenue increase for the first quarter of 2019-20.The startling increase in debt levels from £247.2 million to £384.5 million, a rise of 55.5 per cent, will do little to appease disgruntled fans, unhappy with the way the club is run by the Glazer family owners and executive vice-chairman Ed Woodward.United have posted revenues of £135.4 million for the first quarter of 2019-20, which represents a £400,000 increase on the same period for the previous year.Commercial revenue was £80.4 million, a 5.9 per cent increase on the previous year, but the club are expecting 2020 annual revenue to be down this year to somewhere between £560 million and N580 million, compared to £627.1 million for the year ending June 30, 2019, though the club’s wage bill has dropped slightly.In part that will be due to the club’s lack of Champions League football this season. Broadcasting revenue for the quarter was £32.9 million, a 23.1 per cent and £9.9 million drop on the same quarter the year before.“We have a clear vision in terms of football philosophy and recruitment,” Woodward said. “The significant investments that we have made in recent years in areas such as transfers, recruitment infrastructure, analytics and our academy are already beginning to bear fruit.“We are very proud to be shortly approaching a milestone 4,000th game featuring an academy player, and we are particularly optimistic regarding the considerable young talent currently coming through.“Our ultimate goal is to win trophies by playing exciting football with a team that fuses graduates from our academy with world-class acquisitions.” Tags: Ed Woodwardlast_img read more

Edinburgh too strong for Ulster

first_img Press Association Edinburgh’s interim coaching duo of Steve Scott and Duncan Hodge made a winning start to their tenure when the Scots edged out Ulster 14-8 at Murrayfield to secure only their fifth RaboDirect PRO12 success of the campaign. A try by Stuart McInally plus three penalties by Piers Francis saw the Scots home against an Ulster side for whom Andrew Trimble bagged a try and Paddy Jackson landed a penalty. However, it was Jackson’s lack of accuracy with the boot that proved to be the difference between the sides as he failed with three simple penalties early in the second half. last_img read more

Sherwood hoping for fiery derby

first_img This, though, is the kind of fixture which can give Spurs a timely shot in the arm and Sherwood wants the game to be a throwback to the derby matches he used to play in. “It is a fantastic occasion – always was to play in these games,” the former midfielder told Spurs TV. “It is my first time as a manager at the Lane to be standing opposite Arsene Wenger and hopefully I will get one over on them. “I don’t think there is much blood and thunder these days – I want it to be more of that. “I think that gives us the edge. We are possibly more functional than they are, but if they get into their stride we know they can be very dangerous, so we need to knock them off their stride.” Sherwood’s first match in the dugout for a north London derby came in January, when the Gunners ran out 2-0 victors in their FA Cup third-round tie at the Emirates Stadium. That was the first defeat of his tenure and the pressure has since mounted on the man that succeeded Andre Villas-Boas in December, with talk of a summer departure intensifying as poor results begin to stack up. Sherwood is only concerned with the here and now, however, and is confident his players – whose desire he criticised after the defeat to Chelsea – will do him proud on Sunday. Spurs head into the match in need of a morale-boosting victory after heavy back-to-back defeats this past week at Chelsea and then at home to Benfica in the Europa League. The results likely mean another season without a trophy at White Hart Lane and leaves their top-four ambitions hanging by a thread ahead of Sunday’s pivotal encounter with Arsenal. Tim Sherwood wants this weekend’s north London derby to be a “blood and thunder” encounter as he believes that will give Tottenham the edge. “We’ve got the best game we could have, a north London derby,” he said. “We won’t need any more motivation for that, will we? I am sure they will be up for it. It is probably the best game we could have. “I always thought it was a good time to be playing Arsenal, but it’s ups and downs. We have to soldier on, you can’t always win games and we know that. “We’re in a difficult period at the moment, coming off the back of two defeats, we have to go out there and be counted and I am sure we will and the crowd will accept nothing less.” Emmanuel Adebayor, Kyle Walker and Mousa Dembele are all struggling to be fit for Sunday’s match, while captain Michael Dawson will be absent due to a hamstring injury. Etienne Capoue, Erik Lamela and Vlad Chiriches have also been sidelined, although Gylfi Sigurdsson could be involved after training on Friday. Press Associationlast_img read more